GRANTS


Ongoing


2016-2018

National Institute of Health General Medicine 2 P20 GM103430 Anaerobic Enzymes as

Drug Targets in the Treatment of Amebiasis


2017

Rhode Island NSF-EPSCoR EPS-1004057: Entamoeba spp. as models to explore the effects of

environmental stress due to climate change in marine protists


Completed


2015-2016

National Institute of Health General Medicine 2 P20 GM103430 Anaerobic Enzymes as

Drug Targets in the Treatment of Amebiasis


2015-2016

Rhode Island NSF-EPSCoR EPS-1004057: Entamoeba spp. as models to explore the effects of

environmental stress due to climate change in marine protists


2014-2015

Roger Williams University Foundation Scholarship: Entamoeba spp. use biochemical signaling and

behavioral aggregation to discriminate between members of distinctive varieties


2014-2015

National Institute of Health General Medicine 2 P20 GM103430: Anaerobic Enzymes as Drug

Targets in the Treatment of Amebiasis


2014

Rhode Island NSF-EPSCoR 2014: Using signaling in Entamoeba spp. to explore effects of

environmental stresses (climate change) in marine and fresh water protists


2013-2014

National Institute of Health NIH-NCRR Grant 8P20GM103430-13; Anti-Amoebic Drugs with Less

Toxicity In Humans: Entamoeba histolytica metabolic enzymes as target


2009-2013

National Institute of Health NIH-NCRR Grant # 5P20GM103430 (09-13): The Search for Anti

Amoebic Drugs with Less Toxicity In Humans: Entamoeba histolytica EhADH2 Enzyme As Potential

Target


2012

National Science Foundation-CAREER 0952550 ROA Supplement to support the research project:

Crystal structure(s) of Entamoeba histolytica EhADH2 enzyme and its domains


2008-2011

Merck/AAAS Undergraduate Science Research Award given by the Merck Institute for Science

Education and the American Association for the Advancement of Science

Collaborative biology and chemistry research from molecular to ecosystem scales


2005-2009

National Institute of Health NIH-NCRR Grant # 2 P20 RR16457- 09: The Search for Anti-Amoebic

Drugs with Less Toxicity In Humans: Entamoeba histolytica EhADH2 Enzyme As Potential Target